Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00428428

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract

Sponsor: Fredericia Hosptial

Conditions Benignant Tumour Mass in the Upper Urinary Tract Kidney Stone Unexplained Haematuria

Updated 5 times since 2017 Last updated: Nov 15, 2007 Started: Feb 28, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Benignant Tumour Mass in the Upper Urinary Tract and Kidney Stone, this trial is completed. The trial is conducted by Fredericia Hosptial and has accumulated 5 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fredericia Hosptial

Data source: Fredericia Hosptial

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fredericia, Denmark